Kwon Jung Hyun, Jang Jeong Won, Kim Young Woon, Lee Sung Won, Nam Soon Woo, Jaegal Dongwook, Lee Seungok, Bae Si Hyun
Department of Internal Medicine, Incheon St. Mary's Hospital, The Catholic University of Korea, 56 Dongsu-ro, Bupyeong-gu, Incheon, South Korea.
Department of Internal Medicine, Seoul St. Mary's Hospital, The Catholic University of Korea, 222 Banpo-daero, Seocho-gu, Seoul, South Korea.
BMC Gastroenterol. 2015 Oct 23;15:146. doi: 10.1186/s12876-015-0378-z.
The role of clinical parameters such as systemic inflammatory response syndrome (SIRS) criteria in predicting the infection remains unclear in cirrhosis patients. The aim was to evaluate the usefulness of inflammatory markers including C-reactive protein (CRP) and the neutrophil-to-lymphocyte ratio (NLR) for diagnosis of infection and predicting the outcomes in hospitalized cirrhotic patients.
The study included 184 cirrhotic patients consecutively hospitalized from 2011 to 2012. The presence of overt infection and survival was evaluated. CRP concentration, NLR, Model for End-Stage Liver Disease (MELD) score and the presence of SIRS were assessed.
The main cause of admission was uncontrolled ascites (36.4 %), followed by varix bleeding (23.9 %), and hepatic encephalopathy (13.6 %). Fifty-eight patients (31.5 %) had overt infection during hospitalization and thirty-two patients (17.4 %) expired during the follow up period (median 38 months). Ninety-two patients (52.2 %) fulfilled the SIRS criteria and among them, only 32 patients (38.5 %) had the overt infection. For diagnose of the infection, baseline CRP concentration was a significant factor compared to the presence of SIRS (odds ratio 1.202, P = 0.003). For predicting one-month short-term survival, MELD score, NLR and WBC count were significant factors but in Child-Pugh class C patients, NLR was only an independent factor.
CRP was a significant indicator of infection in hospitalized cirrhotic patients and a NLR was a useful predictor of 1-month survival, particularly in Child-Pugh class C patients. This study suggests that the inflammatory markers such as CRP and NLR can help identify cirrhotic patients at risk of unfavorable outcomes.
在肝硬化患者中,诸如全身炎症反应综合征(SIRS)标准等临床参数在预测感染方面的作用仍不明确。目的是评估包括C反应蛋白(CRP)和中性粒细胞与淋巴细胞比值(NLR)在内的炎症标志物在诊断肝硬化住院患者感染及预测其预后方面的作用。
该研究纳入了2011年至2012年连续住院的184例肝硬化患者。评估显性感染的存在情况及生存率。测定CRP浓度、NLR、终末期肝病模型(MELD)评分以及SIRS的存在情况。
入院的主要原因是腹水控制不佳(36.4%),其次是静脉曲张出血(23.9%)和肝性脑病(13.6%)。58例患者(31.5%)在住院期间发生显性感染,32例患者(17.4%)在随访期内死亡(中位随访时间38个月)。92例患者(52.2%)符合SIRS标准,其中仅有32例患者(38.5%)发生显性感染。对于感染的诊断,与SIRS的存在情况相比,基线CRP浓度是一个显著因素(比值比1.202,P = 0.003)。对于预测1个月短期生存率,MELD评分、NLR和白细胞计数是显著因素,但在Child-Pugh C级患者中,NLR是唯一的独立因素。
CRP是肝硬化住院患者感染的重要指标,NLR是1个月生存率的有用预测指标,尤其是在Child-Pugh C级患者中。本研究表明,CRP和NLR等炎症标志物有助于识别有不良预后风险的肝硬化患者。